Short answer
ClearPoint Neuro, Inc. (CLPT) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 fiscal 2026 results for quarter ended March 31, 2026.
ClearPoint Neuro, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 fiscal 2026 results for quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1 contains financial figures and management commentary
- Results announcement dated May 13, 2026
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation furnished as Exhibit 99.2 for analyst and investor discussions
- Presentation available on ClearPoint Neuro’s investor-relations website
- Reg FD disclosure signals potential updates to company strategy, outlook, or operating priorities давам
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ClearPoint Neuro, Inc. 8-K filings
Get the next CLPT 8-K as it lands
Follow CLPT for push alerts, or ask the research agent what this filing means.